CTRI/2025/08/093473尚未招募1 期
Impact of SCOPE Program on selected parameters among the Patients with Chronic Kidney Disease undergoing Haemodialysis in Puducherry.
B Laxmi Chaitanya1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年9月8日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- RLS
研究概览
简要总结
THE STUDY WILL BE CONDUCTED AFTER GETTING PRIOR PERMIISION AND CONSENT FROM THE SUBJECTS. AFTER COMPLETION OF THE STUDY, THE RESULTS WILL BE PUBLISHED IN THE JOURNALS ACCORDINGLY WITH MENTIONING CTRI NUMBER AFTER APPROVAL.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Undergoing Hemodialysis regularly for more than six weeks Aged 18 to 60 years old Able to understand either English or Tamil Willing to participate in the study.
排除标准
- •Undergoing Hemodialysis for a condition other than CKD Having CKD with other complications.
- •Planned for renal transplant.
- •Planned for transfer to another dialysis setting and undergone any other interventional protocol.
- •Having debilitating other illnesses.
结局指标
主要结局
RLS
时间窗: RLS | FATIGUE | SLEEP QUALITY | QUALITY OF LIFE
FATIGUE
时间窗: RLS | FATIGUE | SLEEP QUALITY | QUALITY OF LIFE
SLEEP QUALITY
时间窗: RLS | FATIGUE | SLEEP QUALITY | QUALITY OF LIFE
QUALITY OF LIFE
时间窗: RLS | FATIGUE | SLEEP QUALITY | QUALITY OF LIFE
次要结局
未报告次要终点
研究者
Bathula Laxmi Chaitanya
Mother Theresa Post Graduate and Research Institute of Health Sciences
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Urinary NGAL and KIM-1 After ESWLNCT07341269Marmara University50
招募中
不适用
A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins ProphylaxisNCT07357038Institute of Hematology & Blood Diseases Hospital, China38
招募中
不适用
Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School StudentsNCT07266857Centre Hospitalier Universitaire de Nice11,000
招募中
不适用
Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal CancerNCT07352280Cancer Institute and Hospital, Chinese Academy of Medical Sciences30
尚未招募
不适用
The impact for fixed dose CombinatiOn of trypsin, chyMotrypsin, Aceclofenac, Paracetamol for MinOr SurgEries (COMPOSE II)CTRI/2025/06/088463Torrent Pharmaceuticals Ltd200